Prolonged Cotrimoxazole Prophylaxis Has No Impact on Child Growth in the First Two Years of Life: Findings from a Randomized Controlled Trial in Botswana.
J Pediatr
; 246: 266-270.e2, 2022 07.
Article
em En
| MEDLINE
| ID: mdl-35351531
We investigated the impact of prolonged cotrimoxazole prophylaxis on growth in 2848 HIV-exposed uninfected children enrolled in the Mpepu study, a randomized, placebo-controlled trial in Botswana. No significant differences in mean weight-for-age, length-for-age, or weight-for-length z scores between placebo and cotrimoxazole arms were observed overall through 18 months.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Infecções por HIV
/
Combinação Trimetoprima e Sulfametoxazol
Tipo de estudo:
Clinical_trials
/
Diagnostic_studies
Limite:
Child
/
Humans
/
Infant
País como assunto:
Africa
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article